OraSure Technologies Inc

Financials

Total assets 464.08 M479.66 M457.61 M445.04 M423.1 M Total liabilities 38.52 M69.32 M61.33 M64.31 M61.12 M Total equity 425.56 M410.34 M396.28 M380.72 M361.98 M Total liabilities & shareholders' equities 464.08 M479.66 M457.61 M445.04 M423.1 M Total debt ————— Net debt —————

OraSure Technologies, Inc. is a Bethlehem, Pennsylvania–based company in the medical device industry. Their products include diagnostic testing kits. The company had recently developed OraQuick testing kit, the first over-the-counter home HIV test.

OSUR

Financials

OraSure Technologies Inc

ニュース

OraSure Technologies, Inc. (OSUR) Q4 2025 Earnings Call Transcript

OraSure: EPS erfüllt Schätzungen - Umsatz schlechter als erwartet

OraSure earnings matched, revenue fell short of estimates

Earnings Call: OraSure Technologies verfehlt Umsatzprognose für Q4 2025

OraSure’s HIV self-test receives Health Canada license

Phibro Animal Health (PAHC) Q2 Earnings and Revenues Surpass Estimates

Altai Capital nominiert zwei Direktoren für Verwaltungsrat von OraSure Technologies/n

Altai Capital nominates two directors for OraSure Technologies board

Unzufriedenheit mit Aktienkurs: Altai Capital nominiert zwei Kandidaten für den Aufsichtsrat von OraSure

Altai Capital nominates two directors to OraSure board amid concerns

OraSure Files for FDA Review of Molecular Self-Test & Colli-Pee Device

OraSure submits FDA applications for rapid STI test and collection device